Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL TESTOSTERONE REPLACEMENT THERAPY INDUSTRY
2.1 Summary about Testosterone Replacement Therapy Industry
2.2 Testosterone Replacement Therapy Market Trends
2.2.1 Testosterone Replacement Therapy Production & Consumption Trends
2.2.2 Testosterone Replacement Therapy Demand Structure Trends
2.3 Testosterone Replacement Therapy Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Gels
4.2.2 Injections
4.2.3 Patches
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Clinics
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Gels
5.2.2 Injections
5.2.3 Patches
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Clinics
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Gels
6.2.2 Injections
6.2.3 Patches
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Clinics
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Gels
7.2.2 Injections
7.2.3 Patches
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Clinics
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Gels
8.2.2 Injections
8.2.3 Patches
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Clinics
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Gels
9.2.2 Injections
9.2.3 Patches
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Clinics
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Endo International
10.1.2 AbbVie
10.1.3 Eli lilly
10.1.4 Pfizer
10.1.5 Actavis (Allergan)
10.1.6 Bayer
10.1.7 Novartis
10.1.8 Teva
10.1.9 Mylan
10.1.10 Upsher-Smith
10.1.11 Ferring Pharmaceuticals
10.1.12 Kyowa Kirin
10.1.13 Acerus Pharmaceuticals
10.2 Testosterone Replacement Therapy Sales Date of Major Players (2017-2020e)
10.2.1 Endo International
10.2.2 AbbVie
10.2.3 Eli lilly
10.2.4 Pfizer
10.2.5 Actavis (Allergan)
10.2.6 Bayer
10.2.7 Novartis
10.2.8 Teva
10.2.9 Mylan
10.2.10 Upsher-Smith
10.2.11 Ferring Pharmaceuticals
10.2.12 Kyowa Kirin
10.2.13 Acerus Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
1.Table Testosterone Replacement Therapy Product Type Overview
2.Table Testosterone Replacement Therapy Product Type Market Share List
3.Table Testosterone Replacement Therapy Product Type of Major Players
4.Table Brief Introduction of Endo International
5.Table Brief Introduction of AbbVie
6.Table Brief Introduction of Eli lilly
7.Table Brief Introduction of Pfizer
8.Table Brief Introduction of Actavis (Allergan)
9.Table Brief Introduction of Bayer
10.Table Brief Introduction of Novartis
11.Table Brief Introduction of Teva
12.Table Brief Introduction of Mylan
13.Table Brief Introduction of Upsher-Smith
14.Table Brief Introduction of Ferring Pharmaceuticals
15.Table Brief Introduction of Kyowa Kirin
16.Table Brief Introduction of Acerus Pharmaceuticals
17.Table Products & Services of Endo International
18.Table Products & Services of AbbVie
19.Table Products & Services of Eli lilly
20.Table Products & Services of Pfizer
21.Table Products & Services of Actavis (Allergan)
22.Table Products & Services of Bayer
23.Table Products & Services of Novartis
24.Table Products & Services of Teva
25.Table Products & Services of Mylan
26.Table Products & Services of Upsher-Smith
27.Table Products & Services of Ferring Pharmaceuticals
28.Table Products & Services of Kyowa Kirin
29.Table Products & Services of Acerus Pharmaceuticals
30.Table Market Distribution of Major Players
31.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
32.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
33.Table Global Testosterone Replacement Therapy Market Forecast (Million USD) by Region 2021f-2026f
34.Table Global Testosterone Replacement Therapy Market Forecast (Million USD) Share by Region 2021f-2026f
35.Table Global Testosterone Replacement Therapy Market Forecast (Million USD) by Demand 2021f-2026f
36.Table Global Testosterone Replacement Therapy Market Forecast (Million USD) Share by Demand 2021f-2026f